Extensior by Abbott and Novo Nordisk expands access to semaglutide therapy in India
Implications: Extensior catapults Abbott into the GLP-1 frenzy,...
March 31, 2026
Author
Ridhi Rastogi
63 Articles
CDSCO to Issue Faster Testing NOCs for Drug Import and Manufacturing Applications
Key Highlights: Implications: Pharma innovators breathe easy as...
MSN Laboratories receives Central Drugs Standard Control Organisation approval for generic Semaglutide
Key Highlights: Implications: MSN joins the generics...
MSD Appoints Brecht Vanneste as Managing Director for India
Key Highlights: Implications: Oncology ace Vanneste...
Bayer’s Nubeqa Receives Expanded Approval in India for mHSPC with ADT
Key Highlights: Implications: Nubeqa’s India approval intensifies...
GSK Survey Highlights Shingles Awareness Gap Among Adults with Chronic Conditions in India
Key Highlights: Implications: Survey hands GSK potent ammo to...
Zydus Lifesciences to Launch Semaglutide Injection in India After Patent Expiry
Key Highlights: Implications: Zydus’ smart-pen assault...
Eris Lifesciences Partners with Natco Pharma to Commercialize Semaglutide in India
Key Highlights: Implications: Semaglutide generics could slash Novo...
Miraqules MedSolutions’s StopBleed Receives Class C Approval from CDSCO
Key Highlights: Implications: StopBleed fills critical...
Novartis AG to transfer 70.68% stake in Novartis India Limited to ChrysCapital
Key Highlights: Implication: This divestment signals multinational pharma...
Trending News
Stay Connected
Get Every Newsletter
Get notified of the best deals on our WordPress themes.